Charles Christensen+FollowBladder Cancer Breakthrough: TAR-200 ShinesDid you see this? TAR-200, a new drug-releasing system, is showing some seriously impressive results for people with high-risk bladder cancer who didn’t respond to BCG. In the latest trial, over 80% of patients stayed disease-free at 9 months, and hardly anyone needed their bladder removed. Side effects were mostly mild and cleared up fast. There’s even a new FDA application in the works—this could be a total game-changer for bladder cancer treatment! #BladderCancer #MedicalBreakthrough #CancerResearch #TAR200 #HealthNews #Health261Share
Kristi Key+FollowBladder Cancer Breakthrough: 82% CR Rate?!TAR-200 is seriously shaking up the bladder cancer world! In the latest SunRISe-1 study, patients with tough-to-treat bladder cancer saw an insane 82.4% complete response rate—and the results actually lasted, with over half still in remission after a year. Even better, most people handled the treatment well, with only mild side effects for the majority. This could be a game-changer for those out of options! #BladderCancer #MedicalBreakthrough #CancerResearch #TAR200 #ClinicalTrials #Health290Share
